Morten Døssing

PersonUnit number: 4006730922
Nørre Farimagsgade 58 1. tv, 1364 København K
0
Ownership
11
Board positions
2
Director positions
0
Other roles
99
People in network
1
Bankruptcy relations

People in network(99)

People who held roles at the same companies, or who co-own the same companies

Søren Sylvester Skjærbæk
Hoba Therapeutics ApS, de novo foundry ApS, HyperBio Therapeutics ApS, Orbis Medicines ApS
Kristian Strømgaard
AVILEX PHARMA ApS, AVILEX PHARMA ApS, AVILEX PHARMA ApS
Claus Elsborg Olesen
NMD Pharma A/S, STIPE Therapeutics ApS, Sulis Therapeutics ApS

Board positions(1)

Orbis Medicines ApS
CVR: 42715646
BESTYRELSESMEDLEM
Active
Since 27. dec. 2024

Director positions(1)

Orbis Medicines ApS
CVR: 42715646
ADM. DIR.
Active
Since 1. feb. 2025

Former board positions(10)

ACESION PHARMA ApS
CVR: 34083738
BESTYRELSESMEDLEM
Ended
Since 9. sep. 2019
Until 15. sep. 2023
AVILEX PHARMA ApS
CVR: 34896828
BESTYRELSESMEDLEM
Ended
Since 21. dec. 2018
Until 6. jun. 2025
NMD Pharma A/S
CVR: 36899069
BESTYRELSESMEDLEM
Ended
Since 15. feb. 2017
Until 13. feb. 2025
Hoba Therapeutics ApS
CVR: 38231170
BESTYRELSESMEDLEM
Ended
Since 28. nov. 2016
Until 8. dec. 2023
de novo foundry ApS
CVR: 38734164
BESTYRELSESMEDLEM
Ended
Since 22. jun. 2022
Until 1. feb. 2025
STIPE Therapeutics ApS
CVR: 39691175
BESTYRELSESMEDLEM
Bankruptcy
Ended
Since 1. okt. 2019
Until 21. aug. 2024
Muna Therapeutics ApS
CVR: 41142871
BESTYRELSESMEDLEM
Ended
Since 15. sep. 2021
Until 30. jan. 2025
HyperBio Therapeutics ApS
CVR: 41244909
FORMAND
Dissolved
Ended
Since 12. mar. 2020
Until 2. jul. 2024
Sulis Therapeutics ApS
CVR: 44445832
BESTYRELSESMEDLEM
Ended
Since 21. nov. 2023
Until 27. jun. 2024
Akylox Therapeutics ApS
CVR: 44974045
FORMAND
Ended
Since 24. sep. 2024
Until 31. jan. 2025

Former director positions(1)

Hoba Therapeutics ApS
CVR: 38231170
DIREKTØR
Ended
Since 28. nov. 2016
Until 1. jan. 2017